A treatment for food allergies, known as Xolair or omalizumab, is being explored as an alternative to oral immunotherapy (OIT). The treatment has shown promise in increasing tolerance to certain food allergens, including peanuts. Its effectiveness is being compared to OIT, with some studies suggesting the two approaches may be comparable in bringing multiple allergens into a person's diet.